Originally developed for type 2 diabetes, it gained popularity for helping people lose weight by reducing appetite
Theres no medical case for stopping a working medication on the assumption that a stronger one will be available in two or three years
Resources We Trust Mayo Clinic: Pros and Cons of GLP-1 Agonists for Weight Loss Yale Medicine: GLP-1 Weight-Loss Pills: What You Need to Know Johns Hopkins University: The Pros, Cons, and Unknowns of Popular Weight-Loss Drugs UC Davis Health: GLP-1 and Health: Beyond Weight Loss in the Ozempic Era Mount Sinai: What Are the Benefits of the New GLP-1 Weight Loss Pills
Other symptoms, like constipation and low energy, further impair weight management efforts
December 31, 2025, 11:05 AM UTC Patent lawsuits involving some of the pharmaceutical industrys most buzzworthy drugs and technologiesincluding the blockbuster weight-loss drug Wegovy and the delivery technology behind Covid-19 vaccinesare set to go to trial in 2026
Wegovy and Zepbound dont replace effort they make effort effective by working with the brain instead of against it